Lumida
/RIGL
⌘K
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc

RIGL
$47.24USD-0.08%-0.04 today

MARKET CAP

882.4M

P/E (TTM)

12.0x

FWD P/E

15.3x

DAY RANGE

$47 – $48

52W RANGE

$25
$52

AI Summary

Stalk
StalkMedium

Despite the medium- and long-term bullish structure under a Stage 2 advance, extreme overbought conditions and an active Bullish Exhaustion pattern signal waning upside follow-through; deferred execution is advised, waiting for a pullback into the rising EMA support zone.

  • Q2 2026 net product sales $67M (+14% YoY)
  • Total Q2 revenues $78.7M; 2026 guidance $275–$290M
  • Intense oncology competition may limit market share gains
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income